StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Aspirin and the Risk of Developing Myocardial Infarction in Patients with Acute Coronary Syndrome - Research Paper Example

Cite this document
Summary
From the paper "Aspirin and the Risk of Developing Myocardial Infarction in Patients with Acute Coronary Syndrome" it is clear that generally, death is significantly reduced if aspirin (150mg daily) is taken daily when myocardial infarction is suspected…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER93.9% of users find it useful
Aspirin and the Risk of Developing Myocardial Infarction in Patients with Acute Coronary Syndrome
Read Text Preview

Extract of sample "Aspirin and the Risk of Developing Myocardial Infarction in Patients with Acute Coronary Syndrome"

? Does aspirin affect the risk of developing myocardial infarction in patients with acute coronary syndrome? Your al affiliationAbstract Myocardial infarction is serious coronary disease and there are many risk factors associated with it. These factors are; age, gender, positive family history of MI, high blood pressure, obesity, high levels of cholesterol, lack of physical activity, diabetes, stress, hypertension, increased serum triglycerides, excessive intake of saturated fats, salt and carbohydrates. Those drugs which are selective cyclooxygenase-2 inhibitors and those that are nonselective nonsteroidal anti-inflammatory, have been shown to increase the risk of reinfarction. This study will be hospital based and hopes to collect enough data to find out whether aspirin increases the risk of developing myocardial infarction in patients with acute coronary syndrome. Myocardial infarctions or acute myocardial infarction (MI) is commonly called heart attack and is a serious disease of coronary which occurs due hardening or narrowing of arteries when cholesterol plaque builds up. Blockage of arteries leads to a major reduction of blood supply, consequently causing necrosis (death or damage) of heart muscles (myocardium) or myocardium ischemia as the heart muscles are not served with oxygenated blood for quite some time (Imagins website:The women health resource,Overview of myocardial infarction, 2009).The infarction site depends on which vessels are involved. For example, if blockage occurs in circumflex coronary artery, this leads to lateral MI while blockage of right coronary artery can lead to right sided heart failures (Imagins website:The women health resource,Overview of myocardial infarction, 2009) There are many predisposing factors to the higher number of MI cases. Some of these factors can be controlled while others cannot. These factors are; age, gender, positive family history of MI, high blood pressure, obesity, high levels of cholesterol, lack of physical activity, diabetes, stress, hypertension, increased serum triglycerides, excessive intake of saturated fats, salt and carbohydrates (Ridker et al, 1998; Salim et al, 2004 ). Other risk factors includes, sedentary life, increased homocysteine and C -resistance proteins and use of drugs such as amphetamines and cocaine (Haffner, Seppo, Tapani, Kalevi and Markku, 1998). About 20% of patients with MI have diabetes (Salim et al, 2004).Obesity on its own or in combination with other factors, increases the risk of developing coronary disease (Khandekar, Khurana, Kakrani, Katdare and Inamdar, 2006). The symptoms of MI are; arm, epigastric and chest pain, breath shortness, diaphoresis, clammy skin dizziness, nausea, vomiting, angina frequency, fatigue, presence of pericardial friction rub, systolic murmurs, bradycardia, hypertension, absence of jagular vein distension, activity intolerance, decreased cardiac output, anxiety, among others (Imagins website:The women health resource,Overview of myocardial infarction, 2009) Diagnosis Diagnosis can be achieved through physical examination of symptoms. Other diagnostic tests which can be used are; detection of elevated levels of homocysteine and C- resistance proteins, electrocardiogram, use of cardiac troposin to differentiate between MI and injury of skeletal muscles. This can also be done through looking at the family history to identify if there is positive relationship. Identification of symptoms is important as this may help a clinician to refer the case to more qualified personnel if need be.The clinician should be able to clarify actual and potential health issues and the associated risk factors. Reflective thinking is also an important component during diagnosis. The clinician should be able to find out if the participation of the patient is optimal, if the data is complete and accurate, if there are assumptions identified and finally if conclusions are drawn from the facts of evidence obtained because there are other possible conclusions which can be drawn from the data obtained (Imagins website:The women health resource,Overview of myocardial infarction, 2009) Those drugs which are selective cyclooxygenase-2 inhibitors and those that are nonselective nonsteroidal anti-inflammatory, have been shown to increase the risk of reinfarction (Gunnar et al, 2006) .Recent studies have shown that, therapeutic trials with aspirin and heparin combination drugs, reduces the risk of incidence of myocardial infarction (Theroux, Walters, Qui, MCcans, P de Guise and Juneau, 1999; Khandekar et al, 2006).These drugs have shown to inhibit platelet formation and thrombin generation (Kandekar et al, 2006).Studies have shown that, dose incomplete generation of thromboxane can lead to occurrence of cardiovascular events (Eikelboom, Jack, Jeffrey, Marilyn, Qulong, Salim, 2002).Those patients with coronary syndrome usually have a range of therapeutic alternatives and the type of therapy used depends on the expected benefits and the clinical presentation of the disease (Boersma et al , 2000) . Studies have also shown that, aspirin reduces the risk of developing cardiovascular events by an estimate of 25% in patients with cardiovascular disease. Nevertheless, it has a limited effectiveness since 10-20% of all patients treated with aspirin and with arterial thrombosis have had recurrence of myocardial infarction at some point in the follow up (Theroux et al, 1999). Aspirin shows its antithrombotic affect by acetylating platelet cyclooxygenase 1 irreversibly and consequently inhibiting synthesis of thromboxane A2.There are also other poorly explained effects of asprin function of platelets but these effects are not certain (Theroux et al, 1999). Death is significantly reduced if aspirin (150mg daily) is taken daily when myocardial infarction is suspected. Treatment can be prescribed regardless of age, sex or diagnosis of diabetes or hypertension. It is beneficial and its risks are minimal. Almost all patients who could be having a myocardial infarction can take this drug and the treatment should be continued for a long term (NHS centerfor reviews and dissemination, 1995).This drug is also easier to administer. Some of the known contradictions or consequences of this drug are; hypersensitivity, peptic ulcers and also bleeding. Contraindications are also seen if a patient is treated with other drugs such as warfarin or any anticoagulant (NHS center for reviews and dissemination, 1995).In addition to this, gastrointestinal complications can also be seen. For those patients with acute myocardial infarction, prompt intravenous thrombolic therapy has been show to be very useful and effective. This is because delays may increase the start of symptoms (NHS center for reviews and dissemination, 1995).Intravenous therapy also reduces death occurrence significantly. Although there are other therapies which can be used instead of aspirin, these drugs are not very effective( NHS center for reviews and dissemination, 1995).Aspirin is prescribed for patients with angina, stroke,transient ischaemia attack, those with previous myocardial events and also for patients with angioplasty or by pass surgery (NHS center for reviews and dissemination, 1995). How aspirin therapy can reduce risk of myocardial infarction, stroke or death (NHS center for reviews and dissemination, 1995). Patient’s history Estimation reduction Previous myocardial infarction 25% Stroke/transient ischemic attack 22% Unstable angina 33% Peripheral vascular and valvular disease 20% For low heart disease and stroke , the approximations are not proven (NHS center for reviews and dissemination, 1995). There are a number of possible explanations of the reasons as to its limited efficacy. Firstly, it is well know that there are many pathways in which platelets can be activated, pathways which in aspirin does not block. In addition, high doses of aspirin ranging from 75- 325mg/d may be needed to obtain optimal antithrombolic effect in some patients (Theroux, et al, 1999). However, studies have shown that low doses of asprin are capable of blocking 95% of platelet cyclooxgynase activity and therefore, it is not very convincing that aspirin antithrombotic activity is linked to its dose (Theroux et al, 1999). This study hopes to determine whether aspirin affects the risk of developing myocardial infarction in patients with acute coronary syndrome. Hypothesis Null hypothesis -Aspirin could affect the risk of developing myocardial infarction in patients with acute coronary syndrome. Methodology Data will be collected as part of routine data collection information. Information on regular intake of aspirin in the month prior to admission and on discharge diagnosis will be collected. Regular intake of aspirin in this case, refers to daily aspirin intake. Information on the duration, dosage and frequency of aspirin use will be recorded. In final analysis of data, those patients whose first diagnosis is likely to be linked with aspirin use such as headache, cancer, different forms of arthritis, gastrointestinal bleeding, alcoholism, psychological disturbances and also anxiety, will be excluded. Those patients who are medically unfit for interview will also be excluded. Research design Follow up design will be used to compare those exposed to aspirin and those not exposed. The fundamental principle of this design is that there are equal risks of developing the myocardial infraction in both case and follow up groups. Data collection Data will be collected using questionnaires and interviews. Interviews will be contacted by trained people to avoid introduction of biasness. The patients will be asked about their past medical histories such as previous hypertension , myocardial infarction, diabetes, arthritis, rheumatic fever and a peptic ulcers. Ethical consideration Since this study will involve collection of information from patients, a written consent will be obtained from the medical institution. This will be particularly important so as to ensure confidentiality of the participants. Follow up and selecting of clinical outcomes All the patients will be followed up till completion of the study to ensure compliance. In each follow up, aspirin use outcomes will be recorded.The main outcome will be myocardial infarction. Statistical analysis of results Both descriptive and inferential statistics will be used. The mean proportion and medians for baseline demographics will be calculated. Multivariate analysis of data will be used to explore the association of aspirin use and the development of myocardial infarction. A multivariate score will be derived to characterize each individual risk of developing myocardial infarction. Such score will include history of myocardial infarction, peptic ulcers, antianginal drug user history. Correlation analysis will also be used to find association between the case and control group. Reporting of findings Information from this study can be shared through publications in journals, conferences or through other media. References Boersma, E., Pieper, K.S., Steyerberg, E.W., Robert, G, W, Wei-Ching, C., Lee, K.L., Martijin, A., Robert, A. H., Jaap, W.D., Armstrong, P.W., Michael, L., Robert, M,C., Eric, J.T and Maarten, L.S (2000). Predictors of outcome in patient with acute coronary syndrome without persistent st-segment elevation:Results from an international trial of 9461 patients ;. Journal of the American Heart association . doi: 10.1161/01.CIR.101.22.2557 NHS center for review and dissemination, N. c. (1995, April1). Effectiveness matters:Aspirin and myocardial infarction. Retrieved from www.york.ac.uk Eikelboom, J.W., Jack, H., Jeffrey, I.W., Marilyn, J., Qulong, Yi., Salim, Y. (2002). Aspirin resistant Thromboxane biosynthesis and the risks of myocardial infarction, stroke or cardiovascular death patients at high risk for cardiovascular events. Circulation , 105, 1650-1655. doi: 10.1161/01.CIR.0000013777.21160.07 Frans Ven de Weif., Jeroen,B., Amadeo, B., Carina,B.L., Filippo,C., Volkmar, F., Gerasimos, F.., Keith,F., Kurt,H., Adam, K., Annika, R.,Gabriel. S.P., Mario,T., Freek,V., Franz,W and Michael,W. (20008)."Management of acute myocardial infarction in patients presenting with persistent ST- segment elevation." European heart journal 29 . doi:10.1093/eurheartj/ehn416 Gunnar, H.G., Soren , J., Jeppe, N.R., Soren, R., Pernille, B., Jens, F., Tina, K.S, Steen, Z.A, Lars, K., Mette, M., Christian, T. P. (2006). Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitor and Nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Journal of Americal Herat Association , 2906-2913. doi: 10.1161/CIRCULATIONAHA.106.616219 Haffner, S.M., Seppo,L., Tapani, R., Kalevi, P and Markku, L.,. "Mortality from coronary heart diseasesin subjects with type 2 diabetes and in non-diabetic subjects with and without myocardial infarction.(1998).The new England journal of medicine 339.4: 229-234. Imagins website:The women health resource,Overview of myocardial infarction. Retrieved from http://www.imaginis.com/heart-disease/heart-disease-myocardial-infarction-heart-attack Khandekar, M.M.,Khurana, A.S., Kakrani, A.L., Katdare, A,D and Inamdar, A.K (2006). Platelet volume indices in patients with coronary artery disease and acute myocardial infarction:an indian scenario. J. Clin Pathol , 59, 146-149. doi: 10.1136/jcp.2004.025387 Ridker, P.M., Nader, Rifai, Marc, A.P., Frank, M.S., Lemuel, A,.M., Steven, G., Greg, C.F and Eugene, B. (1998). Inflammation , pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation , 98, 839-844. doi: 10.1161/01.CIR.98.9.839 Salim, Y., Steven,H., Stephania, O., Tony,D., Alvaro,A., Fernando, L., Mathew, M., Andrzej, B ., Prem, P., John,V and Liu, L. (2004)."Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study ) Case- control study.Retrieved from http://image.thelancet.com Theroux, P., Walters, D., Qui, S., MCcans, J, P de Guise and Juneau, M (1993). Asprin versus heparin to prevent myocardial infarction during the acute phase of nstable angina. Journal of American herat association .Circulation ,88, 2045-2048.doi: 10.1161/01.CIR.88.5.2045 Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Does Aspirin Affect the Risk of Developing Myocardial Infarction in Research Paper”, n.d.)
Does Aspirin Affect the Risk of Developing Myocardial Infarction in Research Paper. Retrieved from https://studentshare.org/health-sciences-medicine/1439661-does-aspirin-affect-the-risk-of-developing
(Does Aspirin Affect the Risk of Developing Myocardial Infarction in Research Paper)
Does Aspirin Affect the Risk of Developing Myocardial Infarction in Research Paper. https://studentshare.org/health-sciences-medicine/1439661-does-aspirin-affect-the-risk-of-developing.
“Does Aspirin Affect the Risk of Developing Myocardial Infarction in Research Paper”, n.d. https://studentshare.org/health-sciences-medicine/1439661-does-aspirin-affect-the-risk-of-developing.
  • Cited: 0 times

CHECK THESE SAMPLES OF Aspirin and the Risk of Developing Myocardial Infarction in Patients with Acute Coronary Syndrome

Acute Myocardial Infarction

The ECG demonstrated an old anterior wall myocardial infarction.... The ECG demonstrated an old anterior wall myocardial infarction.... Acute myocardial infarction Acute myocardial infarction (AMI) is considered to be irreparable myocardial cell death ensuing from ischemia.... Epidemiology Acute myocardial infarction is the most common presentation of ischemic heart disease.... Q- wave infarctions are related with atherosclerosis that comprise major coronary artery, it involves the entire width of the cardiac muscles thereby resulting in absolute occlusion blood supply in that region....
12 Pages (3000 words) Essay

An evaluation of the planning and delivery of nursing care. Acute management of patient with NSTEMI

(2007), NSTEMI constitute a clinical syndrome subset of acute coronary syndrome that is usually caused by Cardiovascular Atherosclerotic Disease and is associated with increased risk of cardiac death and subsequent myocardial infarction.... acute coronary syndrome starts when platelet aggregates clump together and forms a thrombi from a ruptured arteriosclerotic plaque.... individuals are hospitalized for unstable angina and Non ST Elevation myocardial infarction (NSTEMI) (Cannon & O'Gara 2006)....
15 Pages (3750 words) Essay

Approaches to Salvage Damaged Heart Tissue after Myocardial Ischemia

Drugs that interfere with the body's clotting mechanisms can increase the risk of bleeding for patients receiving this drug (Gurm, et.... tPA has been used in diseases that present with risks for blood clots, including pulmonary embolism, myocardial infarction, as well as stroke (Mateen and Nasser, 2009).... For any blockage in the coronary blood vessels, the tPA immediately acts to dissolve such blockage in order to help restore tissue reperfusion (Sheehan and Tsirka, 2005)....
8 Pages (2000 words) Essay

Antithrombotic Therapy in Patients with Atrial Fibrillation

This dissertation "Antithrombotic Therapy in patients with Atrial Fibrillation" is about patients suffering from AF who have higher risks of stroke or thromboembolism.... Some new drugs for treating patients with AF are Dabigatran, Apixaban, Edoxaban and Rivaroxaban, Verapamil, dronedarone, amiodarone, and quinidine.... Atrial fibrillation could be classified as silent atrial fibrillation, atrial fibrillation in the setting of failure of heart, and atrial fibrillation within the setting of myocardial infarction....
34 Pages (8500 words) Dissertation

Coronary Artery Disease Is Epidemic within Western Cultures

If there is any link available between the pathological process and the alteration of the normal physiology of the heart, based on evidence of the lifestyles of these individuals, some directives may be deduced to lessen the risk of development of this disease.... The paper "coronary Artery Disease Is Epidemic within Western Cultures" presents a story of a 60-year-old man diagnosed with severe coronary artery disease, which is the typical picture of older men of the Western world....
11 Pages (2750 words) Essay

Care of Patient in Acute and High Dependency Care

Already mentioned is the decreased arterial oxygen tension, which can aggravate any vascular problem and make elderly patients with circulatory compromise (coronary artery or peripheral artery insufficiency) have more severe symptoms than they would, based on their anatomic vascular disease alone.... Despite the fact that the current care delivery system is not perfect, these rights should never seriously slow down health care professionals and staffs in their continuous pursuit of providing best possible care to their elderly patients especially in cases of Acute myocardial infarction (MI) ....
20 Pages (5000 words) Coursework

Ischemic Heart Problems and Treatment of Symptoms

Of all the arteries in the body, coronary arteries are at increased risk of developing atheroma (Maseri et al, 1992).... From the paper "Ischemic Heart Problems and Treatment of Symptoms" it is clear that heart disease is a condition in which there is oxygen deprivation to the muscles of the heart as a result of decreased blood flow and perfusion and is accompanied by inadequate removal of the products of metabolism....
32 Pages (8000 words) Case Study

Aspirin as a Risk Factor of Developing Myocardial Infarction

This work called "Aspirin as a Risk Factor of Developing Myocardial Infarction" describes the risk of developing myocardial infarction in patients with the acute coronary syndrome.... Obesity on its own or in combination with other factors increases the risk of developing the coronary disease (Khandekar, Khurana, Kakrani, Katdare and Inamdar, 2006).... Those drugs which are selective cyclooxygenase-2 inhibitors and those that are nonselective nonsteroidal anti-inflammatory have been shown to increase the risk of reinfarction....
6 Pages (1500 words) Research Paper
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us